Influenza is an acute respiratory illness that affects the upper or lower respiratory tract and is caused by influenza virus type A or B. An influenza shot is a flu vaccine that protect against the three or four influenza viruses. Influenza circulates continuously, causing seasonal epidemics in temperate regions. Immunization is the major public health measure for the prevention of influenza virus infection.
MARKET DYNAMICS
The pandemic influenza vaccine market is driving due to increasing prevalence of influenza, and increasing compliance with the vaccine worldwide. However, complexity associated with the development of influenza vaccine is expected to hamper the growth of the global pandemic influenza vaccine market. Moreover, increasing research and development activities is anticipated to drive demand the growth of the market.
MARKET SCOPE
The "Pandemic Influenza Vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pandemic influenza vaccine market with detailed market segmentation by type, dosage form and distribution channel. The pandemic influenza vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pandemic influenza vaccine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pandemic influenza vaccine market is segmented based on type, dosage form and distribution channel. Based on type, the market is segmented into trivalent flu vaccines, and quadrivalent flu vaccines. Based on dosage form, the market is segmented into nasal spray, and intradermal shot. Based on distribution channel, the market is segmented into hospitals, clinics, others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pandemic influenza vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pandemic influenza vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pandemic influenza vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the pandemic influenza vaccine market in these regions.
MARKET PLAYERS
The report covers key developments in the pandemic influenza vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pandemic influenza vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pandemic Influenza Vaccine market in the global market. Below mentioned is the list of few companies engaged in the Pandemic Influenza Vaccine market.
The report also includes the profiles of key players in pandemic influenza vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Sanofi
- AstraZeneca
- Seqirus
- Abbott
- GlaxoSmithKline Plc
- Serum Institute of India Pvt. Ltd.
- Zydus Cadila
- BiondVax Pharmaceuticals Ltd.
- Sinovac Biotech Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.